| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SNHG9 | Middle East Respiratory Syndrome Coronavirus (EMC_2012 strain of (MERS-CoV)) | MOI = 3 ;
24 hr |
MRC-5 Human fetal lung fibroblast cells | RNA-Seq | 0.636415113 | Downregulation | 0.013445245 | student's t test | 2020 | 32416070 | |
| SNHG9 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
Calu-3 Human adenocarcinomic lung epithelialcells | RNA-Seq | 0.460349026 | Downregulation | 0.00164016 | student's t test | 2020 | 32416070 | |
| ENSG00000255198 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
Primary Human Bronchial epithelial (NHBE) cells | RNA-Seq | 0.310976681 | Downregulation | 4.12E-05 | two-tailed t-test | 2020 | 32646047 | |
| SNHG9 | Enterovirus D68 (Fermon strain of EV-D68) | MOI = 1 ;
24 hr |
RD Human embryonal rhabdomyosarcoma cells | qPCR | 2.679803111 | Upregulation | p < 0.05 | cufflinks | two-sample t-test | 2021 | 34743709 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose